Victorian researchers have characterised a protein, VDAC2, as a key component of the apoptosis process and resistance to anti-cancer agents such as venetoclax. Walter and Eliza Hall Institute scientists have identified VDAC2 (voltage-dependent anion channel 2) as important for the function of the protein BAX to drive apoptotic cell death. BAX is one of two ...
WEHI apoptosis research may help overcome venetoclax resistance
By Michael Woodhead
5 Dec 2018